Pelthos Therapeutics (PTHS) Return on Assets (2024 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Return on Assets of 0.0% for Q4 2025, up 4.0% year-over-year from 0.0% in Q4 2024, and down 8.35% quarter-over-quarter from 0.0% in Q3 2025.
Pelthos Therapeutics (PTHS) Return on Assets (2024 - 2026) Analysis & Trends
Pelthos Therapeutics' Return on Assets history runs 2 years deep, the most recent figure standing at 0.0% for Q4 2025.
- In Q4 2025, Return on Assets rose 4.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (up 4.0% YoY), while the FY2025 annual figure was 0.01%, up 10.0% from the prior year.
- Return on Assets for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
- The five-year high for Return on Assets was 0.0% in Q3 2025, with the low at 0.06% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Pelthos Therapeutics | 96.56 Mn | 72.00 Mn | 21.23 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.06% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | -0.04% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.04% |